Open AccessAB079. SOH22ABS128. Receptor change on residual disease following neoadjuvant therapies for locally advanced breast cancer fails to impact oncological and survival outcomes
Author(s) -
Rionagh Lynch,
Matthew P. Davey,
Siobhan Connolly,
Tim Harding,
Karl Sweeney,
Carmel Malone,
Michael J. Barry,
Ray McLaughlin,
Aoïfe Lowery,
Michael J. Kerin
Publication year - 2022
Publication title -
mesentery and peritoneum
Language(s) - English
Resource type - Journals
ISSN - 2616-2725
DOI - 10.21037/map-22-ab079
Subject(s) - medicine , breast cancer , oncology , neoadjuvant therapy , overall survival , cancer , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom